RPL11 and breast carcinoma: Oxaliplatin, one of the platinum compounds that is used as a first-line treatment for several types of cancer including breast cancer, has been shown to eradicate cancer cells by inducing cytotoxicity through targeting the ribosomal protein RPL11 49.